{"transactions":[{"id":4613310,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":1864,"kind":"person","name":"Azamian Bobak R.","position":1,"cik":"0001827672","reported_name":"Azamian Bobak R.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President/CEO and Board Chair"}}],"security":"Common Stock","published_at":"2026-09-09T20:14:44.000Z","date":"2026-09-04","kind":"sale","planned":true,"acquired":false,"shares":2900,"price":91.27,"value":264683.0,"ownership":{"direct":false,"nature":"By the Bobak Azamian Living Trust established April 16, 2018"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 9, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in column 4 is a weighted average price. The shares were pooled and sold in multiple transactions at prices ranging from $91.06 to $91.45. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The Reporting Person is the trustee of the Bobak Azamian Living Trust, established April 16, 2018 and has voting and dispositive power with respect to these shares."}],"balance_after":827991,"source":{"system":"sec-edgar","filing":"0001827672-26-000013","document":"wk-form4_1788984881.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1827672/000182767226000013/wk-form4_1788984881.xml","form_type":"4"}},{"id":4613309,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":1864,"kind":"person","name":"Azamian Bobak R.","position":1,"cik":"0001827672","reported_name":"Azamian Bobak R.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President/CEO and Board Chair"}}],"security":"Common Stock","published_at":"2026-09-09T20:14:44.000Z","date":"2026-09-04","kind":"sale","planned":true,"acquired":false,"shares":7100,"price":90.27,"value":640917.0,"ownership":{"direct":false,"nature":"By the Bobak Azamian Living Trust established April 16, 2018"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 9, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is a weighted average price. The shares were pooled and sold in multiple transactions at prices ranging from $90.00 to $90.91. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The Reporting Person is the trustee of the Bobak Azamian Living Trust, established April 16, 2018 and has voting and dispositive power with respect to these shares."}],"balance_after":830891,"source":{"system":"sec-edgar","filing":"0001827672-26-000013","document":"wk-form4_1788984881.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1827672/000182767226000013/wk-form4_1788984881.xml","form_type":"4"}},{"id":2476,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":1864,"kind":"person","name":"Azamian Bobak R.","position":1,"cik":"0001827672","reported_name":"Azamian Bobak R.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President/CEO and Board Chair"}}],"security":"Common Stock","published_at":"2026-09-03T20:30:22.000Z","date":"2026-09-02","kind":"sale","planned":true,"acquired":false,"shares":10000,"price":80.06,"value":800600.0,"ownership":{"direct":false,"nature":"By the Bobak Azamian Living Trust established April 16, 2018"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 9, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is a weighted average price. The shares were pooled and sold in multiple transactions at prices ranging from $80.00 to $80.20. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The Reporting Person is the trustee of the Bobak Azamian Living Trust, established April 16, 2018 and has voting and dispositive power with respect to these shares."}],"balance_after":837991,"source":{"system":"sec-edgar","filing":"0001827672-26-000011","document":"wk-form4_1788467407.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1827672/000182767226000011/wk-form4_1788467407.xml","form_type":"4"}},{"id":730630,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":1864,"kind":"person","name":"Azamian Bobak R.","position":1,"cik":"0001827672","reported_name":"Azamian Bobak R.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President/CEO and Board Chair"}}],"security":"Common Stock","published_at":"2026-06-22T20:09:59.000Z","date":"2026-06-17","kind":"sale","planned":true,"acquired":false,"shares":5418,"price":61.81,"value":334886.58,"ownership":{"direct":false,"nature":"By the Bobak Azamian Living Trust established April 16, 2018"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 9, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in column 4 is a weighted average price. The shares were pooled and sold in multiple transactions at prices ranging from $61.52 to $62.13. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The Reporting Person is the trustee of the Bobak Azamian Living Trust, established April 16, 2018 and has voting and dispositive power with respect to these shares."}],"balance_after":847991,"source":{"system":"sec-edgar","filing":"0001827672-26-000009","document":"wk-form4_1782158996.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000182767226000009/wk-form4_1782158996.xml","form_type":"4"}},{"id":730629,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":1864,"kind":"person","name":"Azamian Bobak R.","position":1,"cik":"0001827672","reported_name":"Azamian Bobak R.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President/CEO and Board Chair"}}],"security":"Common Stock","published_at":"2026-06-22T20:09:59.000Z","date":"2026-06-17","kind":"sale","planned":true,"acquired":false,"shares":4582,"price":61.24,"value":280601.68,"ownership":{"direct":false,"nature":"By the Bobak Azamian Living Trust established April 16, 2018"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 9, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is a weighted average price. The shares were pooled and sold in multiple transactions at prices ranging from $60.51 to $61.50. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The Reporting Person is the trustee of the Bobak Azamian Living Trust, established April 16, 2018 and has voting and dispositive power with respect to these shares."}],"balance_after":853409,"source":{"system":"sec-edgar","filing":"0001827672-26-000009","document":"wk-form4_1782158996.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000182767226000009/wk-form4_1782158996.xml","form_type":"4"}},{"id":833571,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":1864,"kind":"person","name":"Azamian Bobak R.","position":1,"cik":"0001827672","reported_name":"Azamian Bobak R.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President/CEO and Board Chair"}}],"security":"Common Stock","published_at":"2026-03-19T23:03:41.000Z","date":"2026-03-19","kind":"sale","planned":false,"acquired":false,"shares":11964,"price":67,"value":801588.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of Restricted Stock Units. The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the Reporting Person."}],"balance_after":33421,"source":{"system":"sec-edgar","filing":"0001827672-26-000007","document":"wk-form4_1773961418.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000182767226000007/wk-form4_1773961418.xml","form_type":"4"}},{"id":833570,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":1864,"kind":"person","name":"Azamian Bobak R.","position":1,"cik":"0001827672","reported_name":"Azamian Bobak R.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President/CEO and Board Chair"}}],"security":"Common Stock","published_at":"2026-03-19T23:03:41.000Z","date":"2026-03-18","kind":"sale","planned":false,"acquired":false,"shares":11667,"price":68.71,"value":801639.57,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of Restricted Stock Units. The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the Reporting Person."}],"balance_after":45385,"source":{"system":"sec-edgar","filing":"0001827672-26-000007","document":"wk-form4_1773961418.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000182767226000007/wk-form4_1773961418.xml","form_type":"4"}},{"id":833569,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":1864,"kind":"person","name":"Azamian Bobak R.","position":1,"cik":"0001827672","reported_name":"Azamian Bobak R.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President/CEO and Board Chair"}}],"security":"Common Stock","published_at":"2026-03-19T23:03:41.000Z","date":"2026-03-17","kind":"sale","planned":false,"acquired":false,"shares":10972,"price":69.42,"value":761676.24,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of Restricted Stock Units. The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the Reporting Person."}],"balance_after":57052,"source":{"system":"sec-edgar","filing":"0001827672-26-000007","document":"wk-form4_1773961418.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000182767226000007/wk-form4_1773961418.xml","form_type":"4"}},{"id":838200,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":1864,"kind":"person","name":"Azamian Bobak R.","position":1,"cik":"0001827672","reported_name":"Azamian Bobak R.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President/CEO and Board Chair"}}],"security":"Restricted Stock Units","published_at":"2026-03-17T20:24:44.000Z","date":"2026-03-15","kind":"exercise","planned":false,"acquired":false,"shares":14878,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each Restricted Stock Unit represents a contingent right to receive one share of the Company's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"RSUs granted on March 5, 2025, under the Tarsus Pharmaceuticals, Inc. 2020 Stock Plan. 25% of the RSUs will vest on March 15th of each of 2026, 2027, 2028 and 2029, subject to the Reporting Person's continuous service."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"RSUs granted on March 5, 2025, under the Tarsus Pharmaceuticals, Inc. 2020 Stock Plan. 25% of the RSUs will vest on March 15th of each of 2026, 2027, 2028 and 2029, subject to the Reporting Person's continuous service."}],"balance_after":44634,"derivative":{"underlying":"Common Stock","underlying_shares":14878},"source":{"system":"sec-edgar","filing":"0001827672-26-000005","document":"wk-form4_1773779081.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000182767226000005/wk-form4_1773779081.xml","form_type":"4"}},{"id":838199,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":1864,"kind":"person","name":"Azamian Bobak R.","position":1,"cik":"0001827672","reported_name":"Azamian Bobak R.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President/CEO and Board Chair"}}],"security":"Restricted Stock Units","published_at":"2026-03-17T20:24:44.000Z","date":"2026-03-15","kind":"exercise","planned":false,"acquired":false,"shares":23121,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each Restricted Stock Unit represents a contingent right to receive one share of the Company's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"RSUs granted on March 7, 2024, under the Tarsus Pharmaceuticals, Inc. 2020 Stock Plan. 25% of the RSUs will vest on March 15th of each of 2025, 2026, 2027 and 2028, subject to the Reporting Person's continuous service."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"RSUs granted on March 7, 2024, under the Tarsus Pharmaceuticals, Inc. 2020 Stock Plan. 25% of the RSUs will vest on March 15th of each of 2025, 2026, 2027 and 2028, subject to the Reporting Person's continuous service."}],"balance_after":46243,"derivative":{"underlying":"Common Stock","underlying_shares":23121},"source":{"system":"sec-edgar","filing":"0001827672-26-000005","document":"wk-form4_1773779081.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000182767226000005/wk-form4_1773779081.xml","form_type":"4"}},{"id":838198,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":1864,"kind":"person","name":"Azamian Bobak R.","position":1,"cik":"0001827672","reported_name":"Azamian Bobak R.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President/CEO and Board Chair"}}],"security":"Restricted Stock Units","published_at":"2026-03-17T20:24:44.000Z","date":"2026-03-15","kind":"exercise","planned":false,"acquired":false,"shares":16975,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each Restricted Stock Unit represents a contingent right to receive one share of the Company's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"RSUs granted on March 8, 2023, under the Tarsus Pharmaceuticals, Inc. 2020 Stock Plan. 25% of the RSUs will vest on March 15th of each of 2024, 2025, 2026 and 2027, subject to the Reporting Person's continuous service."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"RSUs granted on March 8, 2023, under the Tarsus Pharmaceuticals, Inc. 2020 Stock Plan. 25% of the RSUs will vest on March 15th of each of 2024, 2025, 2026 and 2027, subject to the Reporting Person's continuous service."}],"balance_after":16975,"derivative":{"underlying":"Common Stock","underlying_shares":16975},"source":{"system":"sec-edgar","filing":"0001827672-26-000005","document":"wk-form4_1773779081.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000182767226000005/wk-form4_1773779081.xml","form_type":"4"}},{"id":838197,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":1864,"kind":"person","name":"Azamian Bobak R.","position":1,"cik":"0001827672","reported_name":"Azamian Bobak R.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President/CEO and Board Chair"}}],"security":"Restricted Stock Units","published_at":"2026-03-17T20:24:44.000Z","date":"2026-03-15","kind":"exercise","planned":false,"acquired":false,"shares":11300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each Restricted Stock Unit represents a contingent right to receive one share of the Company's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"RSUs granted on March 9, 2022, under the Tarsus Pharmaceuticals, Inc. 2020 Stock Plan. 25% of the RSUs vested on March 15th of each of 2023, 2024, 2025 and 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"RSUs granted on March 9, 2022, under the Tarsus Pharmaceuticals, Inc. 2020 Stock Plan. 25% of the RSUs vested on March 15th of each of 2023, 2024, 2025 and 2026."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":11300},"source":{"system":"sec-edgar","filing":"0001827672-26-000005","document":"wk-form4_1773779081.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000182767226000005/wk-form4_1773779081.xml","form_type":"4"}},{"id":838196,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":1864,"kind":"person","name":"Azamian Bobak R.","position":1,"cik":"0001827672","reported_name":"Azamian Bobak R.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President/CEO and Board Chair"}}],"security":"Common Stock","published_at":"2026-03-17T20:24:44.000Z","date":"2026-03-15","kind":"exercise","planned":false,"acquired":true,"shares":66274,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares were issued pursuant to settlement of vested Restricted Stock Units (\"RSUs\")."}],"balance_after":68024,"source":{"system":"sec-edgar","filing":"0001827672-26-000005","document":"wk-form4_1773779081.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000182767226000005/wk-form4_1773779081.xml","form_type":"4"}},{"id":853663,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":1864,"kind":"person","name":"Azamian Bobak R.","position":1,"cik":"0001827672","reported_name":"Azamian Bobak R.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President/CEO and Board Chair"}}],"security":"Restricted Stock Units","published_at":"2026-03-09T20:06:22.000Z","date":"2026-03-05","kind":"grant","planned":false,"acquired":true,"shares":60776,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs will vest in four equal annual installments on March 15th of each of 2027, 2028, 2029, and 2030, subject to the Reporting Person's continuous service."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs will vest in four equal annual installments on March 15th of each of 2027, 2028, 2029, and 2030, subject to the Reporting Person's continuous service."}],"balance_after":60776,"derivative":{"underlying":"Common Stock","underlying_shares":60776},"source":{"system":"sec-edgar","filing":"0001827672-26-000003","document":"wk-form4_1773086778.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000182767226000003/wk-form4_1773086778.xml","form_type":"4"}},{"id":853662,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":1864,"kind":"person","name":"Azamian Bobak R.","position":1,"cik":"0001827672","reported_name":"Azamian Bobak R.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President/CEO and Board Chair"}}],"security":"Stock Option (right to buy)","published_at":"2026-03-09T20:06:22.000Z","date":"2026-03-05","kind":"grant","planned":false,"acquired":true,"shares":96723,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the option shares shall vest on March 5, 2027, and 1/48th of the option shares shall vest each month thereafter for a period of 3 years, subject to the Reporting Person's continuous service."}],"balance_after":96723,"derivative":{"exercise_price":74.9,"expiration_date":"2036-03-04","underlying":"Common Stock","underlying_shares":96723},"source":{"system":"sec-edgar","filing":"0001827672-26-000003","document":"wk-form4_1773086778.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000182767226000003/wk-form4_1773086778.xml","form_type":"4"}},{"id":957246,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":1864,"kind":"person","name":"Azamian Bobak R.","position":1,"cik":"0001827672","reported_name":"Azamian Bobak R.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President/CEO and Board Chair"}}],"security":"Common Stock","published_at":"2025-12-30T21:26:13.000Z","date":"2025-12-24","kind":"sale","planned":true,"acquired":false,"shares":557,"price":83.54,"value":46531.78,"ownership":{"direct":false,"nature":"By the Bobak Azamian Living Trust established April 16, 2018"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 12, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in column 4 is a weighted average price. The shares were pooled and sold in multiple transactions at prices ranging from $83.14 to $84.04. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The Reporting Person is the trustee of the Bobak Azamian Living Trust, established April 16, 2018 and has voting and dispositive power with respect to these shares."}],"balance_after":857991,"source":{"system":"sec-edgar","filing":"0001827672-25-000007","document":"wk-form4_1767129970.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000182767225000007/wk-form4_1767129970.xml","form_type":"4"}},{"id":957245,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":1864,"kind":"person","name":"Azamian Bobak R.","position":1,"cik":"0001827672","reported_name":"Azamian Bobak R.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President/CEO and Board Chair"}}],"security":"Common Stock","published_at":"2025-12-30T21:26:13.000Z","date":"2025-12-24","kind":"sale","planned":true,"acquired":false,"shares":5443,"price":82.41,"value":448557.63,"ownership":{"direct":false,"nature":"By the Bobak Azamian Living Trust established April 16, 2018"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 12, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is a weighted average price. The shares were pooled and sold in multiple transactions at prices ranging from $81.89 to $82.88. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The Reporting Person is the trustee of the Bobak Azamian Living Trust, established April 16, 2018 and has voting and dispositive power with respect to these shares."}],"balance_after":858548,"source":{"system":"sec-edgar","filing":"0001827672-25-000007","document":"wk-form4_1767129970.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000182767225000007/wk-form4_1767129970.xml","form_type":"4"}},{"id":977717,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":1864,"kind":"person","name":"Azamian Bobak R.","position":1,"cik":"0001827672","reported_name":"Azamian Bobak R.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President/CEO and Board Chair"}}],"security":"Common Stock","published_at":"2025-12-08T21:06:30.000Z","date":"2025-12-04","kind":"gift","planned":false,"acquired":false,"shares":51885,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"The Reporting Person transferred 51,885 shares of common stock to the Bobak Azamian Living Trust for no consideration. The Reporting Person is the trustee of the Bobak Azamian Living Trust, established April 16, 2018 and has voting and dispositive power with respect to these shares."}],"balance_after":1750,"source":{"system":"sec-edgar","filing":"0001827672-25-000005","document":"wk-form4_1765227987.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000182767225000005/wk-form4_1765227987.xml","form_type":"4"}},{"id":1031780,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":1864,"kind":"person","name":"Azamian Bobak R.","position":1,"cik":"0001827672","reported_name":"Azamian Bobak R.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President/CEO and Board Chair"}}],"security":"Common Stock","published_at":"2025-09-26T20:08:54.000Z","date":"2025-09-24","kind":"sale","planned":true,"acquired":false,"shares":6000,"price":55.37,"value":332220.0,"ownership":{"direct":false,"nature":"By the Bobak Azamian Living Trust established April 16, 2018"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 12, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is a weighted average price. The shares were pooled and sold in multiple transactions at prices ranging from $55.19 to $55.93. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The Reporting Person is the trustee of the Bobak Azamian Living Trust, established April 16, 2018 and has voting and dispositive power with respect to these shares."}],"balance_after":812106,"source":{"system":"sec-edgar","filing":"0001827672-25-000003","document":"wk-form4_1758917331.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000182767225000003/wk-form4_1758917331.xml","form_type":"4"}},{"id":1067873,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":1864,"kind":"person","name":"Azamian Bobak R.","position":1,"cik":"0001827672","reported_name":"Azamian Bobak R.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President/CEO and Board Chair"}}],"security":"Common Stock","published_at":"2025-08-13T20:32:39.000Z","date":"2025-08-11","kind":"sale","planned":true,"acquired":false,"shares":6000,"price":50,"value":300000.0,"ownership":{"direct":false,"nature":"By the Bobak Azamian Living Trust established April 16, 2018"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 12, 2024."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Reporting Person is the trustee of the Bobak Azamian Living Trust, established April 16, 2018 and has voting and dispositive power with respect to these shares."}],"balance_after":818106,"source":{"system":"sec-edgar","filing":"0001819790-25-000110","document":"wk-form4_1755117154.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000181979025000110/wk-form4_1755117154.xml","form_type":"4"}},{"id":1191034,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":1864,"kind":"person","name":"Azamian Bobak R.","position":1,"cik":"0001827672","reported_name":"Azamian Bobak R.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President/CEO and Board Chair"}}],"security":"Common Stock","published_at":"2025-03-26T20:47:19.000Z","date":"2025-03-24","kind":"sale","planned":false,"acquired":false,"shares":6000,"price":50,"value":300000.0,"ownership":{"direct":false,"nature":"By the Bobak Azamian Living Trust established April 16, 2018"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 12, 2024."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Reporting Person is the trustee of the Bobak Azamian Living Trust, established April 16, 2018 and has voting and dispositive power with respect to these shares."}],"balance_after":824106,"source":{"system":"sec-edgar","filing":"0001819790-25-000061","document":"wk-form4_1743022033.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000181979025000061/wk-form4_1743022033.xml","form_type":"4"}},{"id":1195793,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":1864,"kind":"person","name":"Azamian Bobak R.","position":1,"cik":"0001827672","reported_name":"Azamian Bobak R.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President/CEO and Board Chair"}}],"security":"Common Stock","published_at":"2025-03-21T01:48:34.000Z","date":"2025-03-20","kind":"sale","planned":false,"acquired":false,"shares":8534,"price":50.11,"value":427638.74,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of Restricted Stock Units. The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the Reporting Person."}],"balance_after":53635,"source":{"system":"sec-edgar","filing":"0001819790-25-000055","document":"wk-form4_1742521708.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000181979025000055/wk-form4_1742521708.xml","form_type":"4"}},{"id":1195792,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":1864,"kind":"person","name":"Azamian Bobak R.","position":1,"cik":"0001827672","reported_name":"Azamian Bobak R.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President/CEO and Board Chair"}}],"security":"Common Stock","published_at":"2025-03-21T01:48:34.000Z","date":"2025-03-19","kind":"sale","planned":false,"acquired":false,"shares":8551,"price":47.4,"value":405317.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of Restricted Stock Units. The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the Reporting Person."}],"balance_after":62169,"source":{"system":"sec-edgar","filing":"0001819790-25-000055","document":"wk-form4_1742521708.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000181979025000055/wk-form4_1742521708.xml","form_type":"4"}},{"id":1195791,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":1864,"kind":"person","name":"Azamian Bobak R.","position":1,"cik":"0001827672","reported_name":"Azamian Bobak R.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President/CEO and Board Chair"}}],"security":"Common Stock","published_at":"2025-03-21T01:48:34.000Z","date":"2025-03-18","kind":"sale","planned":false,"acquired":false,"shares":7131,"price":46.29,"value":330093.99,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of Restricted Stock Units. The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the Reporting Person."}],"balance_after":70720,"source":{"system":"sec-edgar","filing":"0001819790-25-000055","document":"wk-form4_1742521708.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000181979025000055/wk-form4_1742521708.xml","form_type":"4"}},{"id":1200212,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":1864,"kind":"person","name":"Azamian Bobak R.","position":1,"cik":"0001827672","reported_name":"Azamian Bobak R.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President/CEO and Board Chair"}}],"security":"Restricted Stock Units","published_at":"2025-03-19T01:40:15.000Z","date":"2025-03-15","kind":"exercise","planned":false,"acquired":false,"shares":23121,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of the Company's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"RSUs granted on March 7, 2024, under the Tarsus Pharmaceuticals, Inc. 2020 Stock Plan. 25% of the RSUs will vest on March 15th of each of 2025, 2026, 2027 and 2028, subject to the Reporting Person's continuous service."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"RSUs granted on March 7, 2024, under the Tarsus Pharmaceuticals, Inc. 2020 Stock Plan. 25% of the RSUs will vest on March 15th of each of 2025, 2026, 2027 and 2028, subject to the Reporting Person's continuous service."}],"balance_after":69364,"derivative":{"underlying":"Common Stock","underlying_shares":23121},"source":{"system":"sec-edgar","filing":"0001819790-25-000046","document":"wk-form4_1742348409.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000181979025000046/wk-form4_1742348409.xml","form_type":"4"}},{"id":1200211,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":1864,"kind":"person","name":"Azamian Bobak R.","position":1,"cik":"0001827672","reported_name":"Azamian Bobak R.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President/CEO and Board Chair"}}],"security":"Restricted Stock Units","published_at":"2025-03-19T01:40:15.000Z","date":"2025-03-15","kind":"exercise","planned":false,"acquired":false,"shares":16975,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of the Company's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"RSUs granted on March 8, 2023, under the Tarsus Pharmaceuticals, Inc. 2020 Stock Plan. 25% of the RSUs will vest on March 15th of each of 2024, 2025, 2026 and 2027, subject to the Reporting Person's continuous service."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"RSUs granted on March 8, 2023, under the Tarsus Pharmaceuticals, Inc. 2020 Stock Plan. 25% of the RSUs will vest on March 15th of each of 2024, 2025, 2026 and 2027, subject to the Reporting Person's continuous service."}],"balance_after":33950,"derivative":{"underlying":"Common Stock","underlying_shares":16975},"source":{"system":"sec-edgar","filing":"0001819790-25-000046","document":"wk-form4_1742348409.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000181979025000046/wk-form4_1742348409.xml","form_type":"4"}},{"id":1200210,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":1864,"kind":"person","name":"Azamian Bobak R.","position":1,"cik":"0001827672","reported_name":"Azamian Bobak R.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President/CEO and Board Chair"}}],"security":"Restricted Stock Units","published_at":"2025-03-19T01:40:15.000Z","date":"2025-03-15","kind":"exercise","planned":false,"acquired":false,"shares":11299,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of the Company's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"RSUs granted on March 9, 2022, under the Tarsus Pharmaceuticals, Inc. 2020 Stock Plan. 25% of the RSUs will vest on March 15th of each of 2023, 2024, 2025 and 2026, subject to the Reporting Person's continuous service."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"RSUs granted on March 9, 2022, under the Tarsus Pharmaceuticals, Inc. 2020 Stock Plan. 25% of the RSUs will vest on March 15th of each of 2023, 2024, 2025 and 2026, subject to the Reporting Person's continuous service."}],"balance_after":11300,"derivative":{"underlying":"Common Stock","underlying_shares":11299},"source":{"system":"sec-edgar","filing":"0001819790-25-000046","document":"wk-form4_1742348409.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000181979025000046/wk-form4_1742348409.xml","form_type":"4"}},{"id":1200209,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":1864,"kind":"person","name":"Azamian Bobak R.","position":1,"cik":"0001827672","reported_name":"Azamian Bobak R.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President/CEO and Board Chair"}}],"security":"Common Stock","published_at":"2025-03-19T01:40:15.000Z","date":"2025-03-15","kind":"exercise","planned":false,"acquired":true,"shares":51395,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares were issued pursuant to settlement of vested Restricted Stock Units (\"RSUs\")."}],"balance_after":77851,"source":{"system":"sec-edgar","filing":"0001819790-25-000046","document":"wk-form4_1742348409.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000181979025000046/wk-form4_1742348409.xml","form_type":"4"}},{"id":1217576,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":1864,"kind":"person","name":"Azamian Bobak R.","position":1,"cik":"0001827672","reported_name":"Azamian Bobak R.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President/CEO and Board Chair"}}],"security":"Restricted Stock Units","published_at":"2025-03-07T21:17:46.000Z","date":"2025-03-05","kind":"grant","planned":false,"acquired":true,"shares":59512,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs will vest in four equal annual installments on March 15th of each of 2026, 2027, 2028, and 2029, subject to the Reporting Person's continuous service."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs will vest in four equal annual installments on March 15th of each of 2026, 2027, 2028, and 2029, subject to the Reporting Person's continuous service."}],"balance_after":59512,"derivative":{"underlying":"Common Stock","underlying_shares":59512},"source":{"system":"sec-edgar","filing":"0001819790-25-000022","document":"wk-form4_1741382259.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000181979025000022/wk-form4_1741382259.xml","form_type":"4"}},{"id":1217575,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":1864,"kind":"person","name":"Azamian Bobak R.","position":1,"cik":"0001827672","reported_name":"Azamian Bobak R.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President/CEO and Board Chair"}}],"security":"Stock Option (right to buy)","published_at":"2025-03-07T21:17:46.000Z","date":"2025-03-05","kind":"grant","planned":false,"acquired":true,"shares":90736,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the option  shares shall vest on March 5, 2026, and 1/48th of the option shares shall vest each month thereafter for a period of 3 years, subject to the Reporting Person's continuous service."}],"balance_after":90736,"derivative":{"exercise_price":44.54,"expiration_date":"2035-03-04","underlying":"Common Stock","underlying_shares":90736},"source":{"system":"sec-edgar","filing":"0001819790-25-000022","document":"wk-form4_1741382259.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000181979025000022/wk-form4_1741382259.xml","form_type":"4"}},{"id":1569181,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":1864,"kind":"person","name":"Azamian Bobak R.","position":1,"cik":"0001827672","reported_name":"Azamian Bobak R.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President/CEO and Board Chair"}}],"security":"Restricted Stock Units","published_at":"2024-03-19T23:05:06.000Z","date":"2024-03-15","kind":"exercise","planned":false,"acquired":false,"shares":16975,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each RSU represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"RSUs granted on March 8, 2023, under the Tarsus Pharmaceuticals, Inc. 2020 Stock Plan. The RSUs will vest in equal installments on March 15, 2024, March 15, 2025, March 15, 2026 and March 15, 2027, subject to the Reporting Person's continuous service."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"RSUs granted on March 8, 2023, under the Tarsus Pharmaceuticals, Inc. 2020 Stock Plan. The RSUs will vest in equal installments on March 15, 2024, March 15, 2025, March 15, 2026 and March 15, 2027, subject to the Reporting Person's continuous service."}],"balance_after":50925,"derivative":{"underlying":"Common Stock","underlying_shares":16975},"source":{"system":"sec-edgar","filing":"0001819790-24-000045","document":"wk-form4_1710889492.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000181979024000045/wk-form4_1710889492.xml","form_type":"4"}},{"id":1569180,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":1864,"kind":"person","name":"Azamian Bobak R.","position":1,"cik":"0001827672","reported_name":"Azamian Bobak R.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President/CEO and Board Chair"}}],"security":"Restricted Stock Units","published_at":"2024-03-19T23:05:06.000Z","date":"2024-03-15","kind":"exercise","planned":false,"acquired":false,"shares":11299,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each RSU represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"RSUs granted on March 9, 2022, under the Tarsus Pharmaceuticals, Inc. 2020 Stock Plan. The RSUs will vest in equal installments on March 15, 2023, March 15, 2024, March 15, 2025 and March 15, 2026, subject to the Reporting Person's continuous service."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"RSUs granted on March 9, 2022, under the Tarsus Pharmaceuticals, Inc. 2020 Stock Plan. The RSUs will vest in equal installments on March 15, 2023, March 15, 2024, March 15, 2025 and March 15, 2026, subject to the Reporting Person's continuous service."}],"balance_after":22599,"derivative":{"underlying":"Common Stock","underlying_shares":11299},"source":{"system":"sec-edgar","filing":"0001819790-24-000045","document":"wk-form4_1710889492.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000181979024000045/wk-form4_1710889492.xml","form_type":"4"}},{"id":1569179,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":1864,"kind":"person","name":"Azamian Bobak R.","position":1,"cik":"0001827672","reported_name":"Azamian Bobak R.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President/CEO and Board Chair"}}],"security":"Common Stock","published_at":"2024-03-19T23:05:06.000Z","date":"2024-03-18","kind":"sale","planned":false,"acquired":false,"shares":10415,"price":30.6,"value":318699.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the Reporting Person."}],"balance_after":26456,"source":{"system":"sec-edgar","filing":"0001819790-24-000045","document":"wk-form4_1710889492.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000181979024000045/wk-form4_1710889492.xml","form_type":"4"}},{"id":1569178,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":1864,"kind":"person","name":"Azamian Bobak R.","position":1,"cik":"0001827672","reported_name":"Azamian Bobak R.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President/CEO and Board Chair"}}],"security":"Common Stock","published_at":"2024-03-19T23:05:06.000Z","date":"2024-03-15","kind":"exercise","planned":false,"acquired":true,"shares":28274,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares were issued pursuant to settlement of vested Restricted Stock Units (\"RSUs\")."}],"balance_after":36871,"source":{"system":"sec-edgar","filing":"0001819790-24-000045","document":"wk-form4_1710889492.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000181979024000045/wk-form4_1710889492.xml","form_type":"4"}},{"id":1584381,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":1864,"kind":"person","name":"Azamian Bobak R.","position":1,"cik":"0001827672","reported_name":"Azamian Bobak R.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President/CEO and Board Chair"}}],"security":"Restricted Stock Units","published_at":"2024-03-11T21:57:55.000Z","date":"2024-03-07","kind":"grant","planned":false,"acquired":true,"shares":92485,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"25% of the RSUs will vest on March 15th of each of 2025, 2026, 2027, and 2028, subject to the Reporting Person's continuous service."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"25% of the RSUs will vest on March 15th of each of 2025, 2026, 2027, and 2028, subject to the Reporting Person's continuous service."}],"balance_after":92485,"derivative":{"underlying":"Common Stock","underlying_shares":92485},"source":{"system":"sec-edgar","filing":"0001819790-24-000037","document":"wk-form4_1710194265.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000181979024000037/wk-form4_1710194265.xml","form_type":"4"}},{"id":1584380,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":1864,"kind":"person","name":"Azamian Bobak R.","position":1,"cik":"0001827672","reported_name":"Azamian Bobak R.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President/CEO and Board Chair"}}],"security":"Stock Option (right to buy)","published_at":"2024-03-11T21:57:55.000Z","date":"2024-03-07","kind":"grant","planned":false,"acquired":true,"shares":136947,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the option shares shall vest on March 7, 2025, and 1/48th of the option shares shall vest each month thereafter for a period of 3 years subject to the Reporting Person's continuous service."}],"balance_after":136947,"derivative":{"exercise_price":35.5,"expiration_date":"2034-03-06","underlying":"Common Stock","underlying_shares":136947},"source":{"system":"sec-edgar","filing":"0001819790-24-000037","document":"wk-form4_1710194265.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000181979024000037/wk-form4_1710194265.xml","form_type":"4"}},{"id":1698026,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":1864,"kind":"person","name":"Azamian Bobak R.","position":1,"cik":"0001827672","reported_name":"Azamian Bobak R.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President/CEO and Board Chair"}}],"security":"Common Stock","published_at":"2023-12-29T22:08:49.000Z","date":"2023-12-27","kind":"sale","planned":true,"acquired":false,"shares":8000,"price":20.22,"value":161760.0,"ownership":{"direct":false,"nature":"By the Bobak Azamian Living Trust established April 16, 2018"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 23, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is a weighted average price. The shares were pooled and sold in multiple transactions at prices ranging from $20.00 to $20.43. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The Reporting Person is the trustee of the Bobak Azamian Living Trust, established April 16, 2018 and has voting and dispositive power with respect to these shares."}],"balance_after":830106,"source":{"system":"sec-edgar","filing":"0001827672-23-000050","document":"wk-form4_1703887719.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000182767223000050/wk-form4_1703887719.xml","form_type":"4"}},{"id":1701009,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":1864,"kind":"person","name":"Azamian Bobak R.","position":1,"cik":"0001827672","reported_name":"Azamian Bobak R.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President/CEO and Board Chair"}}],"security":"Common Stock","published_at":"2023-12-22T22:30:34.000Z","date":"2023-12-20","kind":"sale","planned":true,"acquired":false,"shares":30557,"price":20.36,"value":622140.52,"ownership":{"direct":false,"nature":"By the Bobak Azamian Living Trust established April 16, 2018"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 23, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in column 4 is a weighted average price. The shares were pooled and sold in multiple transactions at prices ranging from $20.10 to $20.73. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The Reporting Person is the trustee of the Bobak Azamian Living Trust, established April 16, 2018 and has voting and dispositive power with respect to these shares."}],"balance_after":838106,"source":{"system":"sec-edgar","filing":"0001827672-23-000048","document":"wk-form4_1703284219.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000182767223000048/wk-form4_1703284219.xml","form_type":"4"}},{"id":1701008,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":1864,"kind":"person","name":"Azamian Bobak R.","position":1,"cik":"0001827672","reported_name":"Azamian Bobak R.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President/CEO and Board Chair"}}],"security":"Common Stock","published_at":"2023-12-22T22:30:34.000Z","date":"2023-12-20","kind":"sale","planned":true,"acquired":false,"shares":9443,"price":19.96,"value":188482.28,"ownership":{"direct":false,"nature":"By the Bobak Azamian Living Trust established April 16, 2018"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 23, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is a weighted average price. The shares were pooled and sold in multiple transactions at prices ranging from $19.09 to $20.08. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The Reporting Person is the trustee of the Bobak Azamian Living Trust, established April 16, 2018 and has voting and dispositive power with respect to these shares."}],"balance_after":868663,"source":{"system":"sec-edgar","filing":"0001827672-23-000048","document":"wk-form4_1703284219.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000182767223000048/wk-form4_1703284219.xml","form_type":"4"}},{"id":1736928,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":1864,"kind":"person","name":"Azamian Bobak R.","position":1,"cik":"0001827672","reported_name":"Azamian Bobak R.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President/CEO and Board Chair"}}],"security":"Common Stock","published_at":"2023-11-17T21:50:56.000Z","date":"2023-11-15","kind":"sale","planned":true,"acquired":false,"shares":200,"price":19.28,"value":3856.0,"ownership":{"direct":false,"nature":"By the Bobak Azamian Living Trust established April 16, 2018"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 23, 2023."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The Reporting Person is the trustee of the Bobak Azamian Living Trust, established April 16, 2018 and has voting and dispositive power with respect to these shares."}],"balance_after":878106,"source":{"system":"sec-edgar","filing":"0001827672-23-000045","document":"wk-form4_1700257834.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000182767223000045/wk-form4_1700257834.xml","form_type":"4"}},{"id":1736927,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":1864,"kind":"person","name":"Azamian Bobak R.","position":1,"cik":"0001827672","reported_name":"Azamian Bobak R.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President/CEO and Board Chair"}}],"security":"Common Stock","published_at":"2023-11-17T21:50:56.000Z","date":"2023-11-15","kind":"sale","planned":true,"acquired":false,"shares":4904,"price":18.54,"value":90920.16,"ownership":{"direct":false,"nature":"By the Bobak Azamian Living Trust established April 16, 2018"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 23, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in column 4 is a weighted average price. The shares were pooled and sold in multiple transactions at prices ranging from $18.27 to $19.21. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The Reporting Person is the trustee of the Bobak Azamian Living Trust, established April 16, 2018 and has voting and dispositive power with respect to these shares."}],"balance_after":878306,"source":{"system":"sec-edgar","filing":"0001827672-23-000045","document":"wk-form4_1700257834.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000182767223000045/wk-form4_1700257834.xml","form_type":"4"}},{"id":1736926,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":1864,"kind":"person","name":"Azamian Bobak R.","position":1,"cik":"0001827672","reported_name":"Azamian Bobak R.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President/CEO and Board Chair"}}],"security":"Common Stock","published_at":"2023-11-17T21:50:56.000Z","date":"2023-11-15","kind":"sale","planned":true,"acquired":false,"shares":2896,"price":18.01,"value":52156.96,"ownership":{"direct":false,"nature":"By the Bobak Azamian Living Trust established April 16, 2018"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 23, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is a weighted average price. The shares were pooled and sold in multiple transactions at prices ranging from $17.25 to $18.14. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The Reporting Person is the trustee of the Bobak Azamian Living Trust, established April 16, 2018 and has voting and dispositive power with respect to these shares."}],"balance_after":883210,"source":{"system":"sec-edgar","filing":"0001827672-23-000045","document":"wk-form4_1700257834.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000182767223000045/wk-form4_1700257834.xml","form_type":"4"}},{"id":1756987,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":1864,"kind":"person","name":"Azamian Bobak R.","position":1,"cik":"0001827672","reported_name":"Azamian Bobak R.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President/CEO and Board Chair"}}],"security":"Common Stock","published_at":"2023-10-20T20:41:21.000Z","date":"2023-10-18","kind":"sale","planned":true,"acquired":false,"shares":8000,"price":13.24,"value":105920.0,"ownership":{"direct":false,"nature":"By the Bobak Azamian Living Trust established April 16, 2018"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 23, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is a weighted average price. The shares were pooled and sold in multiple transactions at prices ranging from $13.00 to $13.65. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The Reporting Person is the trustee of the Bobak Azamian Living Trust, established April 16, 2018 and has voting and dispositive power with respect to these shares."}],"balance_after":886106,"source":{"system":"sec-edgar","filing":"0001827672-23-000043","document":"wk-form4_1697834436.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000182767223000043/wk-form4_1697834436.xml","form_type":"4"}},{"id":1774700,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":1864,"kind":"person","name":"Azamian Bobak R.","position":1,"cik":"0001827672","reported_name":"Azamian Bobak R.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President/CEO and Board Chair"}}],"security":"Common Stock","published_at":"2023-09-22T21:30:48.000Z","date":"2023-09-20","kind":"sale","planned":true,"acquired":false,"shares":8000,"price":17.21,"value":137680.0,"ownership":{"direct":false,"nature":"By the Bobak Azamian Living Trust established April 16, 2018"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 23, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is a weighted average price. The shares were pooled and sold in multiple transactions at prices ranging from $16.74 to $17.67. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The Reporting Person is the trustee of the Bobak Azamian Living Trust, established April 16, 2018 and has voting and dispositive power with respect to these shares."}],"balance_after":894106,"source":{"system":"sec-edgar","filing":"0001827672-23-000041","document":"wk-form4_1695418206.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000182767223000041/wk-form4_1695418206.xml","form_type":"4"}},{"id":1796491,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":1864,"kind":"person","name":"Azamian Bobak R.","position":1,"cik":"0001827672","reported_name":"Azamian Bobak R.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President/CEO and Board Chair"}}],"security":"Common Stock","published_at":"2023-08-25T21:12:54.000Z","date":"2023-08-23","kind":"sale","planned":true,"acquired":false,"shares":8000,"price":17.23,"value":137840.0,"ownership":{"direct":false,"nature":"By the Bobak Azamian Living Trust established April 16, 2018"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 23, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is a weighted average price. The shares were pooled and sold in multiple transactions at prices ranging from $17.00 to $17.42. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The Reporting Person is the trustee of the Bobak Azamian Living Trust, established April 16, 2018 and has voting and dispositive power with respect to these shares."}],"balance_after":902106,"source":{"system":"sec-edgar","filing":"0001827672-23-000039","document":"wk-form4_1692997962.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000182767223000039/wk-form4_1692997962.xml","form_type":"4"}},{"id":1824924,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":1864,"kind":"person","name":"Azamian Bobak R.","position":1,"cik":"0001827672","reported_name":"Azamian Bobak R.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President/CEO and Board Chair"}}],"security":"Common Stock","published_at":"2023-07-21T21:42:53.000Z","date":"2023-07-19","kind":"sale","planned":true,"acquired":false,"shares":99726,"price":20.04,"value":1998509.04,"ownership":{"direct":false,"nature":"By the Bobak Azamian Living Trust established April 16, 2018"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 14, 2022"},{"field":"shares","element":"transactionShares","label":"F4","text":"The price reported in column 4 is a weighted average price. The shares were pooled and sold in multiple transactions at prices ranging from $19.73 to $20.12. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The Reporting Person is the trustee of the Bobak Azamian Living Trust, established April 16, 2018 and has voting and dispositive power with respect to these shares."}],"balance_after":910106,"source":{"system":"sec-edgar","filing":"0001827672-23-000037","document":"wk-form4_1689975765.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000182767223000037/wk-form4_1689975765.xml","form_type":"4"}},{"id":1824923,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":1864,"kind":"person","name":"Azamian Bobak R.","position":1,"cik":"0001827672","reported_name":"Azamian Bobak R.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President/CEO and Board Chair"}}],"security":"Common Stock","published_at":"2023-07-21T21:42:53.000Z","date":"2023-07-19","kind":"sale","planned":true,"acquired":false,"shares":4174,"price":19.28,"value":80474.72,"ownership":{"direct":false,"nature":"By the Bobak Azamian Living Trust established April 16, 2018"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 14, 2022"},{"field":"shares","element":"transactionShares","label":"F2","text":"The price reported in column 4 is a weighted average price. The shares were pooled and sold in multiple transactions at prices ranging from $18.69 to $19.66. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The Reporting Person is the trustee of the Bobak Azamian Living Trust, established April 16, 2018 and has voting and dispositive power with respect to these shares."}],"balance_after":1009832,"source":{"system":"sec-edgar","filing":"0001827672-23-000037","document":"wk-form4_1689975765.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000182767223000037/wk-form4_1689975765.xml","form_type":"4"}},{"id":1829613,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":1864,"kind":"person","name":"Azamian Bobak R.","position":1,"cik":"0001827672","reported_name":"Azamian Bobak R.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President/CEO and Board Chair"}}],"security":"Common Stock","published_at":"2023-07-14T20:40:57.000Z","date":"2023-07-12","kind":"sale","planned":true,"acquired":false,"shares":9000,"price":17.35,"value":156150.0,"ownership":{"direct":false,"nature":"By the Bobak Azamian Living Trust established April 16, 2018"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 14, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is a weighted average price. The shares were pooled and sold in multiple transactions at prices ranging from $17.24 to $17.69. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The Reporting Person is the trustee of the Bobak Azamian Living Trust, established April 16, 2018 and has voting and dispositive power with respect to these shares."}],"balance_after":1014006,"source":{"system":"sec-edgar","filing":"0001827672-23-000035","document":"wk-form4_1689367221.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000182767223000035/wk-form4_1689367221.xml","form_type":"4"}},{"id":1845373,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":1864,"kind":"person","name":"Azamian Bobak R.","position":1,"cik":"0001827672","reported_name":"Azamian Bobak R.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President/CEO and Board Chair"}}],"security":"Common Stock","published_at":"2023-06-23T20:29:32.000Z","date":"2023-06-21","kind":"sale","planned":true,"acquired":false,"shares":8000,"price":18.63,"value":149040.0,"ownership":{"direct":false,"nature":"By the Bobak Azamian Living Trust established April 16, 2018"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 14, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is a weighted average price. The shares were pooled and sold in multiple transactions at prices ranging from $18.35 to $18.84. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The Reporting Person is the trustee of the Bobak Azamian Living Trust, established April 16, 2018 and has voting and dispositive power with respect to these shares."}],"balance_after":1023006,"source":{"system":"sec-edgar","filing":"0001819790-23-000048","document":"wk-form4_1687552162.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000181979023000048/wk-form4_1687552162.xml","form_type":"4"}},{"id":1852547,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":1864,"kind":"person","name":"Azamian Bobak R.","position":1,"cik":"0001827672","reported_name":"Azamian Bobak R.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President/CEO and Board Chair"}}],"security":"Common Stock","published_at":"2023-06-16T20:48:55.000Z","date":"2023-06-14","kind":"sale","planned":true,"acquired":false,"shares":9000,"price":18.58,"value":167220.0,"ownership":{"direct":false,"nature":"By the Bobak Azamian Living Trust established April 16, 2018"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 14, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is a weighted average price. The shares were pooled and sold in multiple transactions at prices ranging from $18.17 to $18.95. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The Reporting Person is the trustee of the Bobak Azamian Living Trust, established April 16, 2018 and has voting and dispositive power with respect to these shares."}],"balance_after":1031006,"source":{"system":"sec-edgar","filing":"0001827672-23-000033","document":"wk-form4_1686948523.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000182767223000033/wk-form4_1686948523.xml","form_type":"4"}},{"id":1858983,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":1864,"kind":"person","name":"Azamian Bobak R.","position":1,"cik":"0001827672","reported_name":"Azamian Bobak R.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President/CEO and Board Chair"}}],"security":"Common Stock","published_at":"2023-06-12T21:40:41.000Z","date":"2023-06-08","kind":"sale","planned":true,"acquired":false,"shares":3100,"price":20.01,"value":62031.0,"ownership":{"direct":false,"nature":"By the Bobak Azamian Living Trust established April 16, 2018"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 14, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is a weighted average price. The shares were pooled and sold in multiple transactions at prices ranging from $20.00 to $20.06. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The Reporting Person is the trustee of the Bobak Azamian Living Trust, established April 16, 2018 and has voting and dispositive power with respect to these shares."}],"balance_after":1040006,"source":{"system":"sec-edgar","filing":"0001209191-23-036433","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000120919123036433/doc4.xml","form_type":"4"}},{"id":1884829,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":1864,"kind":"person","name":"Azamian Bobak R.","position":1,"cik":"0001827672","reported_name":"Azamian Bobak R.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President/CEO and Board Chair"}}],"security":"Common Stock","published_at":"2023-05-19T23:08:38.000Z","date":"2023-05-17","kind":"sale","planned":true,"acquired":false,"shares":8000,"price":15.9,"value":127200.0,"ownership":{"direct":false,"nature":"By the Bobak Azamian Living Trust established April 16, 2018"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 14, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is a weighted average price. The shares were pooled and sold in multiple transactions at prices ranging from $15.72 to $16.26. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The Reporting Person is the trustee of the Bobak Azamian Living Trust, established April 16, 2018 and has voting and dispositive power with respect to these shares."}],"balance_after":1043106,"source":{"system":"sec-edgar","filing":"0001827672-23-000031","document":"wf-form4_168453770654909.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000182767223000031/wf-form4_168453770654909.xml","form_type":"4"}},{"id":1895222,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":1864,"kind":"person","name":"Azamian Bobak R.","position":1,"cik":"0001827672","reported_name":"Azamian Bobak R.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President/CEO and Board Chair"}}],"security":"Common Stock","published_at":"2023-05-12T21:08:56.000Z","date":"2023-05-10","kind":"sale","planned":true,"acquired":false,"shares":9000,"price":16.8,"value":151200.0,"ownership":{"direct":false,"nature":"By the Bobak Azamian Living Trust established April 16, 2018"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 14, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is a weighted average price. The shares were pooled and sold in multiple transactions at prices ranging from $16.37 to $17.03. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The Reporting Person is the trustee of the Bobak Azamian Living Trust, established April 16, 2018 and has voting and dispositive power with respect to these shares."}],"balance_after":1051106,"source":{"system":"sec-edgar","filing":"0001827672-23-000030","document":"wf-form4_168392571200364.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000182767223000030/wf-form4_168392571200364.xml","form_type":"4"}},{"id":1908474,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":1864,"kind":"person","name":"Azamian Bobak R.","position":1,"cik":"0001827672","reported_name":"Azamian Bobak R.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President/CEO and Board Chair"}}],"security":"Common Stock","published_at":"2023-05-02T23:06:50.000Z","date":"2023-05-01","kind":"sale","planned":true,"acquired":false,"shares":5841,"price":15.1,"value":88199.1,"ownership":{"direct":false,"nature":"By the Bobak Azamian Living Trust established April 16, 2018"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 14, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in column 4 is a weighted average price. The shares were pooled and sold in multiple transactions at prices ranging from $15.00 to $15.24. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The Reporting Person is the trustee of the Bobak Azamian Living Trust, established April 16, 2018 and has voting and dispositive power with respect to these shares."}],"balance_after":1060106,"source":{"system":"sec-edgar","filing":"0001827672-23-000028","document":"wf-form4_168306879822123.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000182767223000028/wf-form4_168306879822123.xml","form_type":"4"}},{"id":1908473,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":1864,"kind":"person","name":"Azamian Bobak R.","position":1,"cik":"0001827672","reported_name":"Azamian Bobak R.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President/CEO and Board Chair"}}],"security":"Common Stock","published_at":"2023-05-02T23:06:50.000Z","date":"2023-04-28","kind":"sale","planned":true,"acquired":false,"shares":4278,"price":15.13,"value":64726.14,"ownership":{"direct":false,"nature":"By the Bobak Azamian Living Trust established April 16, 2018"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 14, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is a weighted average price. The shares were pooled and sold in multiple transactions at prices ranging from $15.00 to $15.26. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The Reporting Person is the trustee of the Bobak Azamian Living Trust, established April 16, 2018 and has voting and dispositive power with respect to these shares."}],"balance_after":1065947,"source":{"system":"sec-edgar","filing":"0001827672-23-000028","document":"wf-form4_168306879822123.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000182767223000028/wf-form4_168306879822123.xml","form_type":"4"}},{"id":1914241,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":1864,"kind":"person","name":"Azamian Bobak R.","position":1,"cik":"0001827672","reported_name":"Azamian Bobak R.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President/CEO and Board Chair"}}],"security":"Common Stock","published_at":"2023-04-25T21:22:11.000Z","date":"2023-04-21","kind":"sale","planned":true,"acquired":false,"shares":2311,"price":15.03,"value":34734.33,"ownership":{"direct":false,"nature":"By the Bobak Azamian Living Trust established April 16, 2018"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 14, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is a weighted average price. The shares were pooled and sold in multiple transactions at prices ranging from $15.00 to $15.14. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The Reporting Person is the trustee of the Bobak Azamian Living Trust, established April 16, 2018 and has voting and dispositive power with respect to these shares."}],"balance_after":1070225,"source":{"system":"sec-edgar","filing":"0001827672-23-000026","document":"wf-form4_168245771899403.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000182767223000026/wf-form4_168245771899403.xml","form_type":"4"}},{"id":1915665,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":1864,"kind":"person","name":"Azamian Bobak R.","position":1,"cik":"0001827672","reported_name":"Azamian Bobak R.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President/CEO and Board Chair"}}],"security":"Common Stock","published_at":"2023-04-21T21:49:22.000Z","date":"2023-04-19","kind":"sale","planned":true,"acquired":false,"shares":8000,"price":13.6,"value":108800.0,"ownership":{"direct":false,"nature":"By the Bobak Azamian Living Trust established April 16, 2018"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 14, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is a weighted average price. The shares were pooled and sold in multiple transactions at prices ranging from $13.13 to $14.03. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The Reporting Person is the trustee of the Bobak Azamian Living Trust, established April 16, 2018 and has voting and dispositive power with respect to these shares."}],"balance_after":1072536,"source":{"system":"sec-edgar","filing":"0001827672-23-000024","document":"wf-form4_168211375019028.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000182767223000024/wf-form4_168211375019028.xml","form_type":"4"}},{"id":1940280,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":1864,"kind":"person","name":"Azamian Bobak R.","position":1,"cik":"0001827672","reported_name":"Azamian Bobak R.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President/CEO and Board Chair"}}],"security":"Common Stock","published_at":"2023-03-23T23:50:48.000Z","date":"2023-03-23","kind":"sale","planned":false,"acquired":false,"shares":737,"price":12.15,"value":8954.55,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of Restricted Stock Units. The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the Reporting Person."}],"balance_after":8597,"source":{"system":"sec-edgar","filing":"0001827672-23-000022","document":"wf-form4_167961543559554.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000182767223000022/wf-form4_167961543559554.xml","form_type":"4"}},{"id":1940279,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":1864,"kind":"person","name":"Azamian Bobak R.","position":1,"cik":"0001827672","reported_name":"Azamian Bobak R.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President/CEO and Board Chair"}}],"security":"Common Stock","published_at":"2023-03-23T23:50:48.000Z","date":"2023-03-22","kind":"sale","planned":false,"acquired":false,"shares":709,"price":12.64,"value":8961.76,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of Restricted Stock Units. The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the Reporting Person."}],"balance_after":9334,"source":{"system":"sec-edgar","filing":"0001827672-23-000022","document":"wf-form4_167961543559554.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000182767223000022/wf-form4_167961543559554.xml","form_type":"4"}},{"id":1940278,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":1864,"kind":"person","name":"Azamian Bobak R.","position":1,"cik":"0001827672","reported_name":"Azamian Bobak R.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President/CEO and Board Chair"}}],"security":"Common Stock","published_at":"2023-03-23T23:50:48.000Z","date":"2023-03-21","kind":"sale","planned":false,"acquired":false,"shares":679,"price":12.89,"value":8752.31,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of Restricted Stock Units. The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the Reporting Person."}],"balance_after":10043,"source":{"system":"sec-edgar","filing":"0001827672-23-000022","document":"wf-form4_167961543559554.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000182767223000022/wf-form4_167961543559554.xml","form_type":"4"}},{"id":1943205,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":1864,"kind":"person","name":"Azamian Bobak R.","position":1,"cik":"0001827672","reported_name":"Azamian Bobak R.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President/CEO and Board Chair"}}],"security":"Common Stock","published_at":"2023-03-21T23:01:10.000Z","date":"2023-03-20","kind":"sale","planned":false,"acquired":false,"shares":741,"price":12.61,"value":9344.01,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of Restricted Stock Units. The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the Reporting Person."}],"balance_after":10722,"source":{"system":"sec-edgar","filing":"0001827672-23-000020","document":"wf-form4_167943965959717.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000182767223000020/wf-form4_167943965959717.xml","form_type":"4"}},{"id":1943204,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":1864,"kind":"person","name":"Azamian Bobak R.","position":1,"cik":"0001827672","reported_name":"Azamian Bobak R.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President/CEO and Board Chair"}}],"security":"Common Stock","published_at":"2023-03-21T23:01:10.000Z","date":"2023-03-17","kind":"sale","planned":false,"acquired":false,"shares":795,"price":13.28,"value":10557.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of Restricted Stock Units. The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the Reporting Person."}],"balance_after":11463,"source":{"system":"sec-edgar","filing":"0001827672-23-000020","document":"wf-form4_167943965959717.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000182767223000020/wf-form4_167943965959717.xml","form_type":"4"}},{"id":1947322,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":1864,"kind":"person","name":"Azamian Bobak R.","position":1,"cik":"0001827672","reported_name":"Azamian Bobak R.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President/CEO and Board Chair"}}],"security":"Restricted Stock Units","published_at":"2023-03-17T22:02:30.000Z","date":"2023-03-15","kind":"exercise","acquired":false,"shares":11299,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F6","text":"Each RSU represents a contingent right to receive one share of the Company's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"RSU granted on March 9, 2022, under the Tarsus Pharmaceuticals, Inc. 2020 Stock Plan. The RSUs will vest in equal installments on March 15, 2023, March 15, 2024, March 15, 2025 and March 15, 2026, subject to the Reporting Person's continuous service."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"RSU granted on March 9, 2022, under the Tarsus Pharmaceuticals, Inc. 2020 Stock Plan. The RSUs will vest in equal installments on March 15, 2023, March 15, 2024, March 15, 2025 and March 15, 2026, subject to the Reporting Person's continuous service."}],"balance_after":33898,"derivative":{"underlying":"Common Stock","underlying_shares":11299},"source":{"system":"sec-edgar","filing":"0001827672-23-000018","document":"wf-form4_167909053944482.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000182767223000018/wf-form4_167909053944482.xml","form_type":"4"}},{"id":1947321,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":1864,"kind":"person","name":"Azamian Bobak R.","position":1,"cik":"0001827672","reported_name":"Azamian Bobak R.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President/CEO and Board Chair"}}],"security":"Common Stock","published_at":"2023-03-17T22:02:30.000Z","date":"2023-03-16","kind":"sale","acquired":false,"shares":791,"price":13.43,"value":10623.13,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F5","text":"The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale is mandated by the Issuer's election to require the satisfaction of tax withholdingobligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the Reporting Person."}],"balance_after":12258,"source":{"system":"sec-edgar","filing":"0001827672-23-000018","document":"wf-form4_167909053944482.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000182767223000018/wf-form4_167909053944482.xml","form_type":"4"}},{"id":1947320,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":1864,"kind":"person","name":"Azamian Bobak R.","position":1,"cik":"0001827672","reported_name":"Azamian Bobak R.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President/CEO and Board Chair"}}],"security":"Common Stock","published_at":"2023-03-17T22:02:30.000Z","date":"2023-03-15","kind":"exercise","acquired":true,"shares":11299,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"The shares were issued pursuant to settlement of vested Restricted Stock Units (\"RSUs\")."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The shares were issued pursuant to settlement of vested Restricted Stock Units (\"RSUs\")."}],"balance_after":13049,"source":{"system":"sec-edgar","filing":"0001827672-23-000018","document":"wf-form4_167909053944482.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000182767223000018/wf-form4_167909053944482.xml","form_type":"4"}},{"id":1947319,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":1864,"kind":"person","name":"Azamian Bobak R.","position":1,"cik":"0001827672","reported_name":"Azamian Bobak R.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President/CEO and Board Chair"}}],"security":"Common Stock","published_at":"2023-03-17T22:02:30.000Z","date":"2023-03-15","kind":"sale","acquired":false,"shares":8000,"price":13.79,"value":110320.0,"ownership":{"direct":false,"nature":"By the Bobak Azamian Living Trust established April 16, 2018"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 14, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is a weighted average price. The shares were pooled and sold in multiple transactions at prices ranging from $13.52 to $14.28. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The Reporting Person is the trustee of the Bobak Azamian Living Trust, established April 16, 2018 and has voting and dispositive power with respect to these shares."}],"balance_after":1080536,"source":{"system":"sec-edgar","filing":"0001827672-23-000018","document":"wf-form4_167909053944482.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000182767223000018/wf-form4_167909053944482.xml","form_type":"4"}},{"id":1958971,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":1864,"kind":"person","name":"Azamian Bobak R.","position":1,"cik":"0001827672","reported_name":"Azamian Bobak R.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President/CEO and Board Chair"}}],"security":"Restricted Stock Units","published_at":"2023-03-11T00:23:01.000Z","date":"2023-03-08","kind":"grant","acquired":true,"shares":67900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of the Company's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"25% of the RSUs will vest on March 15th of each of 2024, 2025, 2026, and 2027, subject to the Reporting Person's continuous service."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"25% of the RSUs will vest on March 15th of each of 2024, 2025, 2026, and 2027, subject to the Reporting Person's continuous service."}],"balance_after":67900,"derivative":{"underlying":"Common Stock","underlying_shares":67900},"source":{"system":"sec-edgar","filing":"0001209191-23-017996","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000120919123017996/doc4.xml","form_type":"4"}},{"id":1958970,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":1864,"kind":"person","name":"Azamian Bobak R.","position":1,"cik":"0001827672","reported_name":"Azamian Bobak R.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President/CEO and Board Chair"}}],"security":"Stock Option (right to buy)","published_at":"2023-03-11T00:23:01.000Z","date":"2023-03-08","kind":"grant","acquired":true,"shares":100242,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the option shares shall vest on March 8, 2024, and 1/48th of the option shares shall vest each month thereafter for a period of 3 years subject to the Reporting Person's continuous service."}],"balance_after":100242,"derivative":{"exercise_price":15,"expiration_date":"2033-03-08","underlying":"Common Stock","underlying_shares":100242},"source":{"system":"sec-edgar","filing":"0001209191-23-017996","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000120919123017996/doc4.xml","form_type":"4"}},{"id":1958969,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":1864,"kind":"person","name":"Azamian Bobak R.","position":1,"cik":"0001827672","reported_name":"Azamian Bobak R.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President/CEO and Board Chair"}}],"security":"Common Stock","published_at":"2023-03-10T22:13:32.000Z","date":"2023-03-09","kind":"sale","acquired":false,"shares":717,"price":15.01,"value":10762.17,"ownership":{"direct":false,"nature":"By the Bobak Azamian Living Trust established April 16, 2018"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 14, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in column 4 is a weighted average price. The shares were pooled and sold in multiple transactions at prices ranging from $15.00 to $15.07. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The Reporting Person is the trustee of the Bobak Azamian Living Trust, established April 16, 2018 and has voting and dispositive power with respect to these shares."}],"balance_after":1088536,"source":{"system":"sec-edgar","filing":"0001827672-23-000016","document":"wf-form4_167848639670548.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000182767223000016/wf-form4_167848639670548.xml","form_type":"4"}},{"id":1958968,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":1864,"kind":"person","name":"Azamian Bobak R.","position":1,"cik":"0001827672","reported_name":"Azamian Bobak R.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President/CEO and Board Chair"}}],"security":"Common Stock","published_at":"2023-03-10T22:13:32.000Z","date":"2023-03-08","kind":"sale","acquired":false,"shares":4853,"price":15.02,"value":72892.06,"ownership":{"direct":false,"nature":"By the Bobak Azamian Living Trust established April 16, 2018"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 14, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is a weighted average price. The shares were pooled and sold in multiple transactions at prices ranging from $15.00 to $15.15. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The Reporting Person is the trustee of the Bobak Azamian Living Trust, established April 16, 2018 and has voting and dispositive power with respect to these shares."}],"balance_after":1089253,"source":{"system":"sec-edgar","filing":"0001827672-23-000016","document":"wf-form4_167848639670548.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000182767223000016/wf-form4_167848639670548.xml","form_type":"4"}},{"id":2007942,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":1864,"kind":"person","name":"Azamian Bobak R.","position":1,"cik":"0001827672","reported_name":"Azamian Bobak R.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President/CEO and Board Chair"}}],"security":"Common Stock","published_at":"2023-02-17T21:54:55.000Z","date":"2023-02-15","kind":"sale","acquired":false,"shares":8000,"price":15.28,"value":122240.0,"ownership":{"direct":false,"nature":"By the Bobak Azamian Living Trust established April 16, 2018"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 14, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is a weighted average price. The shares were pooled and sold in multiple transactions at prices ranging from $15.03 to $15.40. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The Reporting Person is the trustee of the Bobak Azamian Living Trust, established April 16, 2018 and has voting and dispositive power with respect to these shares."}],"balance_after":1094106,"source":{"system":"sec-edgar","filing":"0001827672-23-000014","document":"wf-form4_167667087235492.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000182767223000014/wf-form4_167667087235492.xml","form_type":"4"}},{"id":2022910,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":1864,"kind":"person","name":"Azamian Bobak R.","position":1,"cik":"0001827672","reported_name":"Azamian Bobak R.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President/CEO and Board Chair"}}],"security":"Common Stock","published_at":"2023-02-10T21:54:13.000Z","date":"2023-02-08","kind":"sale","acquired":false,"shares":9000,"price":15.14,"value":136260.0,"ownership":{"direct":false,"nature":"By the Bobak Azamian Living Trust established April 16, 2018"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 14, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is a weighted average price. The shares were pooled and sold in multiple transactions at prices ranging from $15.03 to $15.53. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The Reporting Person is the trustee of the Bobak Azamian Living Trust, established April 16, 2018 and has voting and dispositive power with respect to these shares."}],"balance_after":1102106,"source":{"system":"sec-edgar","filing":"0001827672-23-000012","document":"wf-form4_167606603017023.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000182767223000012/wf-form4_167606603017023.xml","form_type":"4"}},{"id":2046527,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":1864,"kind":"person","name":"Azamian Bobak R.","position":1,"cik":"0001827672","reported_name":"Azamian Bobak R.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President/CEO and Board Chair"}}],"security":"Common Stock","published_at":"2023-01-25T22:49:07.000Z","date":"2023-01-23","kind":"sale","acquired":false,"shares":4856,"price":15.45,"value":75025.2,"ownership":{"direct":false,"nature":"By the Bobak Azamian Living Trust established April 16, 2018"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 14, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is a weighted average price. The shares were pooled and sold in multiple transactions at prices ranging from $15.00 to $15.70. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The Reporting Person is the trustee of the Bobak Azamian Living Trust, established April 16, 2018 and has voting and dispositive power with respect to these shares."}],"balance_after":1111106,"source":{"system":"sec-edgar","filing":"0001827672-23-000010","document":"wf-form4_167468692702601.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000182767223000010/wf-form4_167468692702601.xml","form_type":"4"}},{"id":2047566,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":1864,"kind":"person","name":"Azamian Bobak R.","position":1,"cik":"0001827672","reported_name":"Azamian Bobak R.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President/CEO and Board Chair"}}],"security":"Common Stock","published_at":"2023-01-24T23:13:23.000Z","date":"2023-01-06","kind":"sale","acquired":false,"shares":411,"price":15,"value":6165.0,"ownership":{"direct":false,"nature":"By the Bobak Azamian Living Trust established April 16, 2018"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 14, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is a weighted average price. The shares were pooled and sold in multiple transactions at prices ranging from $15.00 to $15.04. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"This is an inadvertent late filing due to an administrative error. As a result of this administrative error, the shares sold on January 6, 2023 were erroneously included in the Table I, Column 5 totals of the Form 4s filed by the Reporting Person on January 11, 2023, January 13, 2023 and January 20, 2023."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"The Reporting Person is the trustee of the Bobak Azamian Living Trust, established April 16, 2018 and has voting and dispositive power with respect to these shares."}],"balance_after":1129740,"source":{"system":"sec-edgar","filing":"0001827672-23-000008","document":"wf-form4_167460198945770.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000182767223000008/wf-form4_167460198945770.xml","form_type":"4"}},{"id":2049826,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":1864,"kind":"person","name":"Azamian Bobak R.","position":1,"cik":"0001827672","reported_name":"Azamian Bobak R.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President/CEO and Board Chair"}}],"security":"Common Stock","published_at":"2023-01-20T23:41:51.000Z","date":"2023-01-20","kind":"sale","acquired":false,"shares":240,"price":15,"value":3600.0,"ownership":{"direct":false,"nature":"By the Bobak Azamian Living Trust established April 16, 2018"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 14, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in column 4 is a weighted average price. The shares were pooled and sold in multiple transactions at prices ranging from $15.00 to $15.01. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The Reporting Person is the trustee of the Bobak Azamian Living Trust, established April 16, 2018 and has voting and dispositive power with respect to these shares."}],"balance_after":1116373,"source":{"system":"sec-edgar","filing":"0001827672-23-000006","document":"wf-form4_167425809399971.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000182767223000006/wf-form4_167425809399971.xml","form_type":"4"}},{"id":2049825,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":1864,"kind":"person","name":"Azamian Bobak R.","position":1,"cik":"0001827672","reported_name":"Azamian Bobak R.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President/CEO and Board Chair"}}],"security":"Common Stock","published_at":"2023-01-20T23:41:51.000Z","date":"2023-01-18","kind":"sale","acquired":false,"shares":8000,"price":14.56,"value":116480.0,"ownership":{"direct":false,"nature":"By the Bobak Azamian Living Trust established April 16, 2018"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 14, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is a weighted average price. The shares were pooled and sold in multiple transactions at prices ranging from $14.40 to $14.75. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The Reporting Person is the trustee of the Bobak Azamian Living Trust, established April 16, 2018 and has voting and dispositive power with respect to these shares."}],"balance_after":1116613,"source":{"system":"sec-edgar","filing":"0001827672-23-000006","document":"wf-form4_167425809399971.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000182767223000006/wf-form4_167425809399971.xml","form_type":"4"}},{"id":2054850,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":1864,"kind":"person","name":"Azamian Bobak R.","position":1,"cik":"0001827672","reported_name":"Azamian Bobak R.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President/CEO and Board Chair"}}],"security":"Common Stock","published_at":"2023-01-13T23:47:09.000Z","date":"2023-01-11","kind":"sale","acquired":false,"shares":3904,"price":15.11,"value":58989.44,"ownership":{"direct":false,"nature":"By the Bobak Azamian Living Trust established April 16, 2018"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 14, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is a weighted average price. The shares were pooled and sold in multiple transactions at prices ranging from $15.00 to $15.40. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The Reporting Person is the trustee of the Bobak Azamian Living Trust, established April 16, 2018 and has voting and dispositive power with respect to these shares."}],"balance_after":1124613,"source":{"system":"sec-edgar","filing":"0001827672-23-000004","document":"wf-form4_167365360777704.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000182767223000004/wf-form4_167365360777704.xml","form_type":"4"}},{"id":2056570,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":1864,"kind":"person","name":"Azamian Bobak R.","position":1,"cik":"0001827672","reported_name":"Azamian Bobak R.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President/CEO and Board Chair"}}],"security":"Common Stock","published_at":"2023-01-12T01:26:19.000Z","date":"2023-01-10","kind":"sale","acquired":false,"shares":905,"price":15.17,"value":13728.85,"ownership":{"direct":false,"nature":"By the Bobak Azamian Living Trust established April 16, 2018"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 14, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in column 4 is a weighted average price. The shares were pooled and sold in multiple transactions at prices ranging from $15.00 to $15.42. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The Reporting Person is the trustee of the Bobak Azamian Living Trust, established April 16, 2018 and has voting and dispositive power with respect to these shares."}],"balance_after":1128517,"source":{"system":"sec-edgar","filing":"0001827672-23-000002","document":"wf-form4_167348676340762.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000182767223000002/wf-form4_167348676340762.xml","form_type":"4"}},{"id":2056569,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":1864,"kind":"person","name":"Azamian Bobak R.","position":1,"cik":"0001827672","reported_name":"Azamian Bobak R.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President/CEO and Board Chair"}}],"security":"Common Stock","published_at":"2023-01-12T01:26:19.000Z","date":"2023-01-09","kind":"sale","acquired":false,"shares":729,"price":15.15,"value":11044.35,"ownership":{"direct":false,"nature":"By the Bobak Azamian Living Trust established April 16, 2018"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 14, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is a weighted average price. The shares were pooled and sold in multiple transactions at prices ranging from $15.02 to $15.34. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The Reporting Person is the trustee of the Bobak Azamian Living Trust, established April 16, 2018 and has voting and dispositive power with respect to these shares."}],"balance_after":1129422,"source":{"system":"sec-edgar","filing":"0001827672-23-000002","document":"wf-form4_167348676340762.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000182767223000002/wf-form4_167348676340762.xml","form_type":"4"}},{"id":2077762,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":1864,"kind":"person","name":"Azamian Bobak R.","position":1,"cik":"0001827672","reported_name":"Azamian Bobak R.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President/CEO and Board Chair"}}],"security":"Common Stock","published_at":"2022-12-22T23:02:17.000Z","date":"2022-12-21","kind":"sale","acquired":false,"shares":8000,"price":14.57,"value":116560.0,"ownership":{"direct":false,"nature":"By the Bobak Azamian Living Trust established April 16, 2018"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 14, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is a weighted average price. The shares were pooled and sold in multiple transactions at prices ranging from $14.37 to $14.80. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The Reporting Person is the trustee of the Bobak Azamian Living Trust, established April 16, 2018 and has voting and dispositive power with respect to these shares."}],"balance_after":1130151,"source":{"system":"sec-edgar","filing":"0001827672-22-000020","document":"wf-form4_167175011949009.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000182767222000020/wf-form4_167175011949009.xml","form_type":"4"}},{"id":2079961,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":1864,"kind":"person","name":"Azamian Bobak R.","position":1,"cik":"0001827672","reported_name":"Azamian Bobak R.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President/CEO and Board Chair"}}],"security":"Common Stock","published_at":"2022-12-20T23:35:28.000Z","date":"2022-12-16","kind":"sale","acquired":false,"shares":535,"price":15.01,"value":8030.35,"ownership":{"direct":false,"nature":"By the Bobak Azamian Living Trust established April 16, 2018"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 14, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is a weighted average price. The shares were pooled and sold in multiple transactions at prices ranging from $15.00 to $15.04. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The Reporting Person is the trustee of the Bobak Azamian Living Trust, established April 16, 2018 and has voting and dispositive power with respect to these shares."}],"balance_after":1138151,"source":{"system":"sec-edgar","filing":"0001827672-22-000018","document":"wf-form4_167157931321935.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000182767222000018/wf-form4_167157931321935.xml","form_type":"4"}},{"id":2083895,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":1864,"kind":"person","name":"Azamian Bobak R.","position":1,"cik":"0001827672","reported_name":"Azamian Bobak R.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President/CEO and Board Chair"}}],"security":"Common Stock","published_at":"2022-12-16T21:51:47.000Z","date":"2022-12-14","kind":"sale","acquired":false,"shares":6420,"price":15.08,"value":96813.6,"ownership":{"direct":false,"nature":"By the Bobak Azamian Living Trust established April 16, 2018"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 14, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is a weighted average price. The shares were pooled and sold in multiple transactions at prices ranging from $15.00 to $15.28. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The Reporting Person is the trustee of the Bobak Azamian Living Trust, established April 16, 2018 and has voting and dispositive power with respect to these shares."}],"balance_after":1138686,"source":{"system":"sec-edgar","filing":"0001827672-22-000016","document":"wf-form4_167122749083590.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000182767222000016/wf-form4_167122749083590.xml","form_type":"4"}},{"id":2110504,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":1864,"kind":"person","name":"Azamian Bobak R.","position":1,"cik":"0001827672","reported_name":"Azamian Bobak R.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2022-11-18T21:09:45.000Z","date":"2022-11-16","kind":"sale","acquired":false,"shares":745,"price":17.31,"value":12895.95,"ownership":{"direct":false,"nature":"By the Bobak Azamian Living Trust established April 16, 2018"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 14, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in column 4 is a weighted average price. The shares were pooled and sold in multiple transactions at prices ranging from $17.24 to $17.51. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The Reporting Person is the trustee of the Bobak Azamian Living Trust, established April 16, 2018 and has voting and dispositive power with respect to these shares."}],"balance_after":1145106,"source":{"system":"sec-edgar","filing":"0001827672-22-000014","document":"wf-form4_166880576794208.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000182767222000014/wf-form4_166880576794208.xml","form_type":"4"}},{"id":2110503,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":1864,"kind":"person","name":"Azamian Bobak R.","position":1,"cik":"0001827672","reported_name":"Azamian Bobak R.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2022-11-18T21:09:45.000Z","date":"2022-11-16","kind":"sale","acquired":false,"shares":7255,"price":16.81,"value":121956.55,"ownership":{"direct":false,"nature":"By the Bobak Azamian Living Trust established April 16, 2018"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 14, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is a weighted average price. The shares were pooled and sold in multiple transactions at prices ranging from $16.24 to $17.23. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The Reporting Person is the trustee of the Bobak Azamian Living Trust, established April 16, 2018 and has voting and dispositive power with respect to these shares."}],"balance_after":1145851,"source":{"system":"sec-edgar","filing":"0001827672-22-000014","document":"wf-form4_166880576794208.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000182767222000014/wf-form4_166880576794208.xml","form_type":"4"}},{"id":2118154,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":1864,"kind":"person","name":"Azamian Bobak R.","position":1,"cik":"0001827672","reported_name":"Azamian Bobak R.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2022-11-14T21:25:58.000Z","date":"2022-11-09","kind":"sale","acquired":false,"shares":9000,"price":17.87,"value":160830.0,"ownership":{"direct":false,"nature":"By the Bobak Azamian Living Trust established April 16, 2018"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 14, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is a weighted average price. The shares were pooled and sold in multiple transactions at prices ranging from $17.49 to $18.31. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The Reporting Person is the trustee of the Bobak Azamian Living Trust, established April 16, 2018 and has voting and dispositive power with respect to these shares."}],"balance_after":1153106,"source":{"system":"sec-edgar","filing":"0001827672-22-000012","document":"wf-form4_166846112850981.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000182767222000012/wf-form4_166846112850981.xml","form_type":"4"}},{"id":2133623,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":1864,"kind":"person","name":"Azamian Bobak R.","position":1,"cik":"0001827672","reported_name":"Azamian Bobak R.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2022-10-21T20:23:56.000Z","date":"2022-10-19","kind":"sale","acquired":false,"shares":100,"price":17.6,"value":1760.0,"ownership":{"direct":false,"nature":"By the Bobak Azamian Living Trust established April 16, 2018"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 14, 2022."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The Reporting Person is the trustee of the Bobak Azamian Living Trust, established April 16, 2018 and has voting and dispositive power with respect to these shares."}],"balance_after":1162106,"source":{"system":"sec-edgar","filing":"0001827672-22-000010","document":"wf-form4_166638381380111.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000182767222000010/wf-form4_166638381380111.xml","form_type":"4"}},{"id":2133622,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":1864,"kind":"person","name":"Azamian Bobak R.","position":1,"cik":"0001827672","reported_name":"Azamian Bobak R.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2022-10-21T20:23:56.000Z","date":"2022-10-19","kind":"sale","acquired":false,"shares":7900,"price":16.91,"value":133589.0,"ownership":{"direct":false,"nature":"By the Bobak Azamian Living Trust established April 16, 2018"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 14, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is a weighted average price. The shares were pooled and sold in multiple transactions at prices ranging from $16.51 to $17.37. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The Reporting Person is the trustee of the Bobak Azamian Living Trust, established April 16, 2018 and has voting and dispositive power with respect to these shares."}],"balance_after":1162206,"source":{"system":"sec-edgar","filing":"0001827672-22-000010","document":"wf-form4_166638381380111.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000182767222000010/wf-form4_166638381380111.xml","form_type":"4"}},{"id":2137109,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":1864,"kind":"person","name":"Azamian Bobak R.","position":1,"cik":"0001827672","reported_name":"Azamian Bobak R.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2022-10-14T20:32:12.000Z","date":"2022-10-12","kind":"sale","acquired":false,"shares":2821,"price":16.24,"value":45813.04,"ownership":{"direct":false,"nature":"By the Bobak Azamian Living Trust established April 16, 2018"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 14, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in column 4 is a weighted average price. The shares were pooled and sold in multiple transactions at prices ranging from $16.21 to $16.32. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The Reporting Person is the trustee of the Bobak Azamian Living Trust, established April 16, 2018 and has voting and dispositive power with respect to these shares."}],"balance_after":1170106,"source":{"system":"sec-edgar","filing":"0001827672-22-000008","document":"wf-form4_166577950145627.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000182767222000008/wf-form4_166577950145627.xml","form_type":"4"}},{"id":2137108,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":1864,"kind":"person","name":"Azamian Bobak R.","position":1,"cik":"0001827672","reported_name":"Azamian Bobak R.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2022-10-14T20:32:12.000Z","date":"2022-10-12","kind":"sale","acquired":false,"shares":6179,"price":15.76,"value":97381.04,"ownership":{"direct":false,"nature":"By the Bobak Azamian Living Trust established April 16, 2018"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 14, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is a weighted average price. The shares were pooled and sold in multiple transactions at prices ranging from $15.14 to $16.04. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The Reporting Person is the trustee of the Bobak Azamian Living Trust, established April 16, 2018 and has voting and dispositive power with respect to these shares."}],"balance_after":1172927,"source":{"system":"sec-edgar","filing":"0001827672-22-000008","document":"wf-form4_166577950145627.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000182767222000008/wf-form4_166577950145627.xml","form_type":"4"}},{"id":2152087,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":1864,"kind":"person","name":"Azamian Bobak R.","position":1,"cik":"0001827672","reported_name":"Azamian Bobak R.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2022-09-23T22:08:56.000Z","date":"2022-09-21","kind":"sale","acquired":false,"shares":100,"price":17.045,"value":1704.5,"ownership":{"direct":false,"nature":"By the Bobak Azamian Living Trust established April 16, 2018"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 14, 2022."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The Reporting Person is the trustee of the Bobak Azamian Living Trust, established April 16, 2018 and has voting and dispositive power with respect to these shares."}],"balance_after":1179106,"source":{"system":"sec-edgar","filing":"0001209191-22-051179","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000120919122051179/doc4.xml","form_type":"4"}},{"id":2152086,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":1864,"kind":"person","name":"Azamian Bobak R.","position":1,"cik":"0001827672","reported_name":"Azamian Bobak R.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2022-09-23T22:08:56.000Z","date":"2022-09-21","kind":"sale","acquired":false,"shares":7900,"price":16.3,"value":128770.0,"ownership":{"direct":false,"nature":"By the Bobak Azamian Living Trust established April 16, 2018"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 14, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is a weighted average price. The shares were pooled and sold in multiple transactions at prices ranging from $15.96 to $16.94. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The Reporting Person is the trustee of the Bobak Azamian Living Trust, established April 16, 2018 and has voting and dispositive power with respect to these shares."}],"balance_after":1179206,"source":{"system":"sec-edgar","filing":"0001209191-22-051179","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000120919122051179/doc4.xml","form_type":"4"}},{"id":2157484,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":1864,"kind":"person","name":"Azamian Bobak R.","position":1,"cik":"0001827672","reported_name":"Azamian Bobak R.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2022-09-16T20:28:59.000Z","date":"2022-09-14","kind":"sale","acquired":false,"shares":9000,"price":16.01,"value":144090.0,"ownership":{"direct":false,"nature":"By the Bobak Azamian Living Trust established April 16, 2018"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 14, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is a weighted average price. The shares were pooled and sold in multiple transactions at prices ranging from $15.51 to $16.37. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The Reporting Person is the trustee of the Bobak Azamian Living Trust, established April 16, 2018 and has voting and dispositive power with respect to these shares."}],"balance_after":1187106,"source":{"system":"sec-edgar","filing":"0001827672-22-000006","document":"wf-form4_166336012093561.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000182767222000006/wf-form4_166336012093561.xml","form_type":"4"}},{"id":2178410,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":1864,"kind":"person","name":"Azamian Bobak R.","position":1,"cik":"0001827672","reported_name":"Azamian Bobak R.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2022-08-19T20:49:34.000Z","date":"2022-08-17","kind":"sale","acquired":false,"shares":736,"price":17.44,"value":12835.84,"ownership":{"direct":false,"nature":"By the Bobak Azamian Living Trust established April 16, 2018"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 14, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in column 4 is a weighted average price. The shares were pooled and sold in multiple transactions at prices ranging from $17.22 to $17.56. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The Reporting Person is the trustee of the Bobak Azamian Living Trust, established April 16, 2018 and has voting and dispositive power with respect to these shares."}],"balance_after":1196106,"source":{"system":"sec-edgar","filing":"0001827672-22-000004","document":"wf-form4_166094216194304.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000182767222000004/wf-form4_166094216194304.xml","form_type":"4"}},{"id":2178409,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":1864,"kind":"person","name":"Azamian Bobak R.","position":1,"cik":"0001827672","reported_name":"Azamian Bobak R.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2022-08-19T20:49:34.000Z","date":"2022-08-17","kind":"sale","acquired":false,"shares":7264,"price":16.5,"value":119856.0,"ownership":{"direct":false,"nature":"By the Bobak Azamian Living Trust established April 16, 2018"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 14, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is a weighted average price. The shares were pooled and sold in multiple transactions at prices ranging from $16.11 to $16.82. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The Reporting Person is the trustee of the Bobak Azamian Living Trust, established April 16, 2018 and has voting and dispositive power with respect to these shares."}],"balance_after":1196842,"source":{"system":"sec-edgar","filing":"0001827672-22-000004","document":"wf-form4_166094216194304.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000182767222000004/wf-form4_166094216194304.xml","form_type":"4"}},{"id":2337819,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":1864,"kind":"person","name":"Azamian Bobak R.","position":1,"cik":"0001827672","reported_name":"Azamian Bobak R.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Restricted Stock Units","published_at":"2022-03-11T21:19:41.000Z","date":"2022-03-09","kind":"grant","acquired":true,"shares":45197,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of the Company's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"25% of the RSUs will vest on March 15th of each of 2023, 2024, 2025, and 2026, subject to the Reporting Person's continuous service."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"25% of the RSUs will vest on March 15th of each of 2023, 2024, 2025, and 2026, subject to the Reporting Person's continuous service."}],"balance_after":45197,"derivative":{"underlying":"Common Stock","underlying_shares":45197},"source":{"system":"sec-edgar","filing":"0001827672-22-000002","document":"wf-form4_164703352044513.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000182767222000002/wf-form4_164703352044513.xml","form_type":"4"}},{"id":2337818,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":1864,"kind":"person","name":"Azamian Bobak R.","position":1,"cik":"0001827672","reported_name":"Azamian Bobak R.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (right to buy)","published_at":"2022-03-11T21:19:41.000Z","date":"2022-03-09","kind":"grant","acquired":true,"shares":154067,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the option shares shall vest on March 9, 2023, and 1/48th of the option shares shall vest each month thereafter for a period of 3 years subject to the Reporting Person's continuous service."}],"balance_after":154067,"derivative":{"exercise_price":19.59,"expiration_date":"2032-03-08","underlying":"Common Stock","underlying_shares":154067},"source":{"system":"sec-edgar","filing":"0001827672-22-000002","document":"wf-form4_164703352044513.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000182767222000002/wf-form4_164703352044513.xml","form_type":"4"}},{"id":2486312,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":1864,"kind":"person","name":"Azamian Bobak R.","position":1,"cik":"0001827672","reported_name":"Azamian Bobak R.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-12-03T23:55:23.000Z","date":"2021-12-01","kind":"sale","acquired":false,"shares":578,"price":26.76,"value":15467.28,"ownership":{"direct":false,"nature":"By the Bobak Azamian Living Trust established April 16, 2018"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 14, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported in column 4 is a weighted average price. The shares were pooled and sold in multiple transactions at prices ranging from $26.57 to $27.19. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The Reporting Person is the trustee of the Bobak Azamian Living Trust, established April 16, 2018 and has voting and dispositive power with respect to these shares."}],"balance_after":1204106,"source":{"system":"sec-edgar","filing":"0001819790-21-000057","document":"wf-form4_163857571118270.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000181979021000057/wf-form4_163857571118270.xml","form_type":"4"}},{"id":2486311,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":1864,"kind":"person","name":"Azamian Bobak R.","position":1,"cik":"0001827672","reported_name":"Azamian Bobak R.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-12-03T23:55:23.000Z","date":"2021-12-01","kind":"sale","acquired":false,"shares":760,"price":25.9,"value":19684.0,"ownership":{"direct":false,"nature":"By the Bobak Azamian Living Trust established April 16, 2018"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 14, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in column 4 is a weighted average price. The shares were pooled and sold in multiple transactions at prices ranging from $25.33 to $26.26. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The Reporting Person is the trustee of the Bobak Azamian Living Trust, established April 16, 2018 and has voting and dispositive power with respect to these shares."}],"balance_after":1204684,"source":{"system":"sec-edgar","filing":"0001819790-21-000057","document":"wf-form4_163857571118270.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000181979021000057/wf-form4_163857571118270.xml","form_type":"4"}},{"id":2486310,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":1864,"kind":"person","name":"Azamian Bobak R.","position":1,"cik":"0001827672","reported_name":"Azamian Bobak R.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-12-03T23:55:23.000Z","date":"2021-12-01","kind":"sale","acquired":false,"shares":2101,"price":24.7,"value":51894.7,"ownership":{"direct":false,"nature":"By the Bobak Azamian Living Trust established April 16, 2018"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 14, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in column 4 is a weighted average price. The shares were pooled and sold in multiple transactions at prices ranging from $24.3 to $25.28. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The Reporting Person is the trustee of the Bobak Azamian Living Trust, established April 16, 2018 and has voting and dispositive power with respect to these shares."}],"balance_after":1205444,"source":{"system":"sec-edgar","filing":"0001819790-21-000057","document":"wf-form4_163857571118270.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000181979021000057/wf-form4_163857571118270.xml","form_type":"4"}},{"id":2486309,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":1864,"kind":"person","name":"Azamian Bobak R.","position":1,"cik":"0001827672","reported_name":"Azamian Bobak R.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-12-03T23:55:23.000Z","date":"2021-12-01","kind":"sale","acquired":false,"shares":2394,"price":23.86,"value":57120.84,"ownership":{"direct":false,"nature":"By the Bobak Azamian Living Trust established April 16, 2018"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 14, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is a weighted average price. The shares were pooled and sold in multiple transactions at prices ranging from $23.28 to $24.22. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The Reporting Person is the trustee of the Bobak Azamian Living Trust, established April 16, 2018 and has voting and dispositive power with respect to these shares."}],"balance_after":1207545,"source":{"system":"sec-edgar","filing":"0001819790-21-000057","document":"wf-form4_163857571118270.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000181979021000057/wf-form4_163857571118270.xml","form_type":"4"}}],"next_cursor":"2021-12-03T23:55:23.000000Z,2486309"}